5 Lung Cancer Clinical Trials in Madison, WI (2026)

Q: How do I join a clinical trial in Madison?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you.

Recruiting Lung Cancer Studies in Madison

NCT03175224Recruiting

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

To assess: * efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification, solid tumors harboring MET amplification, solid...

Madison, WIPHASE2497 participantsApollomics Inc.

View Study Details

NCT05742607Recruiting

IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)

The study is intended to assess the safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab in ...

Madison, WIPHASE270 participantsInnate Pharma

View Study Details

NCT07132918Recruiting

HEARTS Trial for Thoracic Cancers

The goal of this clinical trial is to compare a new way of using magnetic resonance-guided adaptive radiation therapy (MRgART) to the standard of care linear accelerator (LINAC) radiation treatment in...

Madison, WIPHASE260 participantsUniversity of Wisconsin, Madison

View Study Details

NCT04919382Recruiting

Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer that has spread to other places in the body (metasta...

Madison, WIPHASE256 participantsDwight Owen

View Study Details

NCT05068232Recruiting

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

This this study is for individuals who have treatment-naïve extensive-stage small cell lung cancer (small cell lung cancer that wont respond to treatment). Doctors leading this study hope to learn if ...

Madison, WIPHASE249 participantsUniversity of Chicago

View Study Details

About Lung Cancer Clinical Trials in Madison

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 5 lung cancer clinical trials recruiting participants in Madison, WI. These studies are seeking a combined 732 participants. Research is being sponsored by Apollomics Inc., Innate Pharma, University of Wisconsin, Madison and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Madison — FAQ

Are there lung cancer clinical trials in Madison?

Yes, there are 5 lung cancer clinical trials currently recruiting in Madison, WI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Madison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you about next steps.

Are clinical trials in Madison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madison studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 5 active trials in Madison are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 19, 2026 from ClinicalTrials.gov